Seattle, WA · Founded 2006 · Privately Held (backing)
Developer of a blood-collection system designed to eliminate sepsis misdiagnosis due to the preventable error of false-positive blood culture results caused by contamination. Magnolia Medical Technologies is based in Seattle, WA and was founded in 2006. It was valued at $244 million at its growth round in Jan 2025, the last priced event on record. It has raised $184 million across 6 recorded rounds; the latest was a $43.4 million early-stage round in Jan 2022.
PMV mark · valuation
$244.0M
Oct 2026
Priced at
its growth round
Jan 2025
Total raised
$183.9M
Last round
Early Stage VC
Jan 2022
No prints on record
No secondary trades in Magnolia Medical Technologies shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Magnolia Medical Technologies with a free account
·The complete investor list: 22 names
·Watch Magnolia Medical Technologies: the Monday email on marks, rounds and moves
Where Magnolia Medical Technologies prices come from
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Magnolia Medical Technologies stock.
